1. Home >
  2. M&A >
  3. Joint Venture >
  4. Norway >
  5. Lindsay Goldberg and Aker BioMarine ASA Acquire Trygg Pharma

M&A Deal Summary

Lindsay Goldberg and Aker BioMarine ASA Acquire Trygg Pharma

On November 1, 2010, private equity firm Lindsay Goldberg and Aker BioMarine ASA acquired life science company Trygg Pharma

Acquisition Highlights
  • This is Lindsay Goldberg’s 1st and Aker BioMarine ASA’s 1st transaction in the Life Science sector.
  • This is Lindsay Goldberg’s 2nd and Aker BioMarine ASA’s 1st transaction in Norway.

M&A Deal Summary
Date 2010-11-01
Target Trygg Pharma
Sector Life Science
Buyer(s) Lindsay Goldberg
Aker BioMarine ASA
Deal Type Joint Venture

Target

Trygg Pharma

Oslo, Norway
Trygg Pharma is a Norwegian-based 50/50 joint venture with Aker BioMarine. TPH is a manufacturer of marine-based omega-3 EPA/DHA concentrates for nutraceutical and pharmaceutical applications. EPAX, TPH’s nutraceutical division, is a long-standing leader in marine-based omega-3 EPA/DHA fatty acid concentrates for nutraceutical manufacturers and marketers, with a focus on the high concentrate segment. Trygg Pharma, TPH’s pharmaceutical division, is completing a Phase III FDA study on an omega-3-based drug candidate for hypertriglyceridemia. Trygg Pharma was founded in 2009 and is based in Oslo, Norway.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 2

Buyer

Lindsay Goldberg

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2001
PE ASSETS 17.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Lindsay Goldberg is a large private equity firm that targets investments in traditional, basic industries. Lindsay looks to commit $50 to $250 million per transaction in sectors that include basic & commodity manufacturing, financial services, food, and distribution. Lindsay looks to partner with management in pursuing transactions. Lindsay Goldberg was formerly known as Lindsay Goldberg & Bessemer. The Firm was formed in 2001 and is based in New York City.

DEAL STATS #
Overall 22 of 58
Sector: Life Science M&A 1 of 2
Type: Joint Venture M&A Deals 1 of 3
Country: Norway M&A 2 of 2
Year: 2010 M&A 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-09-20 Aviv REIT

Chicago, Illinois, United States

Aviv REIT, Inc. is a real estate investment trust that specializes in owning post-acute and long-term care SNFs and other healthcare properties.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-02-22 PAE

Falls Church, Virginia, United States

PAE is a provider of support for the essential missions of the U.S. government, its allied partners, and international organizations. With over 60 years of experience, the company supports the execution of complex and critical missions by providing global logistics and stability operations, technical services and national security solutions to customers around the world. PAE was formed in 1955 and is based in Falls Church, Virginia.

Buy -
Buyer

Aker BioMarine ASA

Oslo, Norway
Category Company
Sector Life Science
DESCRIPTION

Aker BioMarine is an integrated biotechnology company – uniquely positioned to create value from krill harvesting and processing.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Joint Venture M&A Deals 1 of 1
Country: Norway M&A 1 of 1
Year: 2010 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-07-09 Aker BioMarine - Feed Ingredients Business

Norway

Aker BioMarine's Feed Ingredients Business is an industrial-scale krill harvester and brings a natural, sustainable, and health-promoting source of nutrients into both animal and human nutrition.

Sell -
Mergr

Solution for

Product

Company

Legal